Euro2.1 Million for Research
Barcelona - Spanish CrystaX Pharmaceuticals S.L. has raised Euro2.1 million in financing. The round was led with Euro1.5 million from Najeti Capital, and backed up with Euro300,000 each from Invertec and Barcelona Emprèn. The funds will be applied to research.
CrystaX is a biotechnology company specialized in structure-based drug discovery. In order to find candidate compounds for new pharmaceuticals, it uses processes ranging from gene cloning, 3D structure elucidation of pharmacological targets to virtual fragment screening.